The March issue of the CHR VOICE is running a few days late because we knew that we had to address the CORONA virus and how CHR is responding to the public health crisis to protect the safety of our patients, staff and everyone in the community. But whenever we set down to write the article, new developments occurred, CDC advice changed and/or other public statements from different organizations had to be considered. As of this moment, March 12, 2020, when these pages are being finalized, what you will be reading represents CHR’s most up-to-date understanding of what the current situation is and requires. Possibly, maybe even likely, by the time you will be reading these pages, this information may already be outdated. We, therefore, can only advise you to remain informed through news media and official government announcements on city, state and federal levels.
In this issue of the CHR VOICE, we cover:
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
DISCOVER YOUR TREATMENT OPTIONS
